Fabrizio Vincenzi

University of Ferrara

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Neuroscience Neuroscience professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

ALESSANDRO PAPA

Università degli Studi di Siena

ITALY

View details

Michele Morari

University of Ferrara

ITALY

View details

Stephanie Federico

Tenured professor

University of Trieste

ITALY

View details

Vittoria Colotta

University of Florence

ITALY

View details

Natascia Mennini

Università degli Studi di Napoli Federico II

ITALY

View details

Stefania Butini

Professore associato

Università degli Studi di Siena

ITALY

View details

Katia Varani

Associate Professor

University of Ferrara

ITALY

View details

Rosa Maria Gaudio

professore associato Dirigente medico

University of Ferrara

ITALY

View details

Sandra Gemma

Professore Associato

Università degli Studi di Siena

ITALY

View details

Martina Canton

University of Padua

ITALY

View details

Anna Fantinati

University of Ferrara

ITALY

View details

Stefano Moro

Professor of Medicinal Chemistry

University of Padova

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fabrizio Vincenzi

Research Interests

Explore related searches

Contact this professor

Articles (13)

Synthesis and Biological Evaluation of Novel 2-Aroyl Benzofuran-Based Hydroxamic Acids as Antimicrotubule Agents

A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients

Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors

Front Cover: Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors (ChemMedChem 14/2023)

Pharmacology of Adenosine Receptors: Recent Advancements

Caffeine for Prevention of Alzheimer’s Disease: Is the A<sub>2A</sub> Adenosine Receptor Its Target?

Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy

Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice

A<sub>2A</sub> Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity?

4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives

Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice

Pathophysiological Role and Medicinal Chemistry of A<sub>2A</sub> Adenosine Receptor Antagonists in Alzheimer’s Disease

Collaborators (12)

ALESSANDRO PAPA

Michele Morari

Stephanie Federico

Vittoria Colotta

Natascia Mennini

Stefania Butini

Katia Varani

Rosa Maria Gaudio

Sandra Gemma

Martina Canton

Anna Fantinati

Stefano Moro

Make your next move.

Fabrizio Vincenzi

Research Interests

Explore related searches

Contact this professor

Articles (13)

Synthesis and Biological Evaluation of Novel 2-Aroyl Benzofuran-Based Hydroxamic Acids as Antimicrotubule Agents

A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients

Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors

Front Cover: Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors (ChemMedChem 14/2023)

Pharmacology of Adenosine Receptors: Recent Advancements

Caffeine for Prevention of Alzheimer’s Disease: Is the A<sub>2A</sub> Adenosine Receptor Its Target?

Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy

Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice

A<sub>2A</sub> Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity?

4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives

Dopamine Transporter, PhosphoSerine129 &alpha;-Synuclein and &alpha;-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice

Pathophysiological Role and Medicinal Chemistry of A<sub>2A</sub> Adenosine Receptor Antagonists in Alzheimer&rsquo;s Disease

Collaborators (12)

ALESSANDRO PAPA

Michele Morari

Stephanie Federico

Vittoria Colotta

Natascia Mennini

Stefania Butini

Katia Varani

Rosa Maria Gaudio

Sandra Gemma

Martina Canton

Anna Fantinati

Stefano Moro

Make your next move.

Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice

Pathophysiological Role and Medicinal Chemistry of A<sub>2A</sub> Adenosine Receptor Antagonists in Alzheimer’s Disease